Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

TMO A A DGX Funds Advertising Convertibles Housewares 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Collecting data for NDZ

Nordion quote and profile

 
 Companies |  Insiders  | Dashboard  
     
7.54
  
STOCK
(0.08)  Macroaxis: -1.05 Down   1.05%  
Year To Date
5.5110.96
Last 1 Month(s)
7.128.02
Trading Day 
7.57.6
June 18 2013 

Diversification Suggestion

Use Nordion to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly
Analyze Nordion Inc Trend or Check current 30 days Nordion correlation with market (S&P 500)
1 Month Beta 0.32  
Highest Price:  
Lowest Price:  
8.02  
7.12  
May 23 2013 
May 21 2013 
As returns on market increase, Nordion returns are expected to increase less than the market. However during bear market, the loss on holding Nordion will be expected to be smaller as well.
Nordion Inc Small BetaNordion Inc Beta Legend
NDZ United States NYSE
Nordion Inc
Healthcare
Medical Laboratories and Research
Benchmark S&P 500
http://www.mdsnordion.com
Contact Number: 613. 592. 2790
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation408.54 M
Shares Outstanding61.91 M
Number of Shares Shorted351.16 K
Revenue245.49 M
 United States Russel   1.23 % Macroaxis: change 1.23 Moved Up  
 
 United States SP 500   0.78 % Macroaxis: 0.78 Moved Up  
 
 United States NYSE   0.66 % Macroaxis: 0.66 Moved Up  
 
 thisRed NDZ NDZ agains markets  1.05 % Macroaxis: change 1.05 Moved Down  
 
Compare to Competition Alpha & Beta   Get Advice

Nordion Leadership

Steve West CEO and President Director, Member of Technology Committee and Interim COO of Targeted Therapies
Steven West President CEO, Non-Independent Director
William Dempsey Director, Chairman of HR and Compensation Committee and Member of Technology Committee
William Anderson Non-Executive Independent Chairman of the Board

Nordion Price and Market Media

The median price of Nordion for the period between Sun, May 19, 2013 and Tue, Jun 18, 2013 is 7.7 with a coefficient of variation of 3.14. The daily time series for the period is distributed with a sample standard deviation of 0.24, arithmetic mean of 7.64, and mean deviation of 0.16. The Stock received substential amount of media coverage during this period.
Nordion         SP 500
Price Growth (%)
 
Change Benchmark  Embed  Export  Timeline
1
Nordion Rating Lowered to Reduce at TD Securities05/29/2013Macroaxis: News
2
quotEuropean Nuclear Medicine Radiopharmaceuticals Market an...05/31/2013Macroaxis: News
3
NORDION INC Nordion Reports Second Quarter Fiscal 2013 Finan...06/06/2013Macroaxis: News
4
Nordion Given New 9.00 Price Target at RBC Capital06/12/2013Macroaxis: News

Nordion Summary

Nordion Inc [NDZ] is traded on New York Stock Exchange in USA. It is located in Ottawa, ON KK X and employs 500 people. The company currently falls under 'Small-Cap' category with total capitalization of 496.51 M. Nordion Inc runs under Healthcare sector within Medical Laboratories and Research industry. This company has 61.91 M outstanding shares of which 351.16 K shares are now shorted by investors with about 3.1 days to cover shorted positions.
Nordion Inc. offer solutions and services for the prevention, diagnosis, and treatment of diseases worldwide. more
Past Market
Over 30
Days
5
Out Of
100
 
Chance of
Less
Than
%
 
Follow Nordion with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Nordion to your reader
 

Nordion Research Report

Nordion vs. Thermo

Correlation analysis and fundamentals comparison between Nordion Inc and Thermo Fisher Scientific

Nordion Executives

Peter Dans CFO and Sr. VP
G Dans CFO, MBA

Nordion Directors

Ana Raman Director of Investor Relations
Sean Murphy Independent Director
Robert Luba Independent Director
Kenneth Newport Independent Director
Janet Woodruff Independent Director

Nordion Management

Kevin Brooks Sr. VP of Sales and Marketing
Peter Covitz Sr. VP of Innovation, Ph.D

Nordion Fundamentals

Debt to Equity vs Cash per Share
Z Score vs Operating Margin
Debt to Equity vs Net Income
One Year Low vs Operating Margin

Nordion vs Competition

Nordion vs. Thermo Fisher Scientific Inc
Nordion vs. Agilent Technologies Inc
Nordion vs. MettlerToledo International Inc
Nordion vs. Covance Inc

Nordion June 18 2013 Opportunity Range

Downside Deviation1.38
Information Ratio0.1397
Maximum Drawdown15.38
Value At Risk(1.79)
Potential Upside1.16

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium